| Trial ID: | L4198 |
| Source ID: | NCT01980524
|
| Associated Drug: |
Acipimox
|
| Title: |
The Impact of Free Fatty Acid (FFA-) Suppression on Myocardial Lipids and Function in Patients With Type 2 Diabetes
|
| Acronym: |
HYPOTESIS
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT01980524/results
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: acipimox|DRUG: Placebo Oral Capsule
|
| Outcome Measures: |
Primary: MYCL, Intramyocardiocellular lipid content (MYCL) before and after administration of acipimox or placebo, 180 minutes | Secondary: Ejection Fraction, Left ventricular ejection fraction before and after administration of acipimox or placebo, 180 minutes | Other: Stroke Volume, Stroke volume before and after administration of acipimox or placebo, 180 minutes
|
| Sponsor/Collaborators: |
Sponsor: Medical University of Vienna
|
| Gender: |
ALL
|
| Age: |
ADULT
|
| Phases: |
PHASE2|PHASE3
|
| Enrollment: |
8
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (PARTICIPANT)|Primary Purpose: BASIC_SCIENCE
|
| Start Date: |
2013-10
|
| Completion Date: |
2016-05
|
| Results First Posted: |
2017-04-04
|
| Last Update Posted: |
2017-04-04
|
| Locations: |
Division of Endocrinology and Metabolism, Internal Medicine III, Medical University of Vienna, Vienna, 1090, Austria
|
| URL: |
https://clinicaltrials.gov/show/NCT01980524
|
